Encompass Health (EHC) CEO Mark Tarr Sells ~173,148 Shares

What Happened
Mark J. Tarr, President & CEO and a director of Encompass Health Corporation (EHC), sold a total of 173,148 shares in open-market transactions on August 10, 2026. The sales consisted of 171,569 shares at a weighted-average price of $125.46 (proceeds ≈ $21,525,047) and 1,579 shares at a weighted-average price of $126.06 (proceeds ≈ $199,049), for combined proceeds of roughly $21.7 million. These were sales (not purchases or option exercises).

Key Details

• Transaction date: 2026-08-10 (Form 4 filed 2026-08-11 — timely filing).
• Sale details:
  • 171,569 shares @ $125.46 (weighted average); total ≈ $21,525,047. Footnote: prices in this block ranged from $124.93 to $125.92.
  • 1,579 shares @ $126.06 (weighted average); total ≈ $199,049. Footnote: prices in this block ranged from $125.93 to $126.22.
• Transaction type: Open-market sale (code "S").
• Shares owned after the transaction: not disclosed in the information you provided (check the full Form 4 for post-transaction beneficial ownership).
• Footnotes: both per-share prices are weighted averages across multiple trades; the filer offers to provide breakdowns by individual trade price on request.

Context

• Sales by executives can be routine (e.g., diversification, tax planning, or planned selling programs) and do not, by themselves, indicate company performance. This filing documents the sale details and amount realized but does not state the reason for the sale.
• No option exercises, awards, or gift transactions are reported here — these were outright share disposals in the open market.